Impacts of Methylenetetrahydrofolate Reductase Genotypes on Hallux Valgus
- PMID: 39740879
- PMCID: PMC11705133
- DOI: 10.21873/invivo.13815
Impacts of Methylenetetrahydrofolate Reductase Genotypes on Hallux Valgus
Abstract
Background/aim: Hallux valgus (HV) is the most common deformity of the forefoot. Although HV has been strongly associated with a family history, its genetic underpinnings remain unclear. Few studies have examined the relationship between folic acid metabolism, which is critical in normal bone development, and HV. The study aimed to investigate the contribution of methylenetetrahydrofolate reductase (MTHFR) genotypes to the risk of HV.
Materials and methods: The MTHFR rs1801133 and rs1801131 genotypes were analyzed in 150 patients with HV and 600 controls without HV, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Results: The results highlighted a significant difference in the genotypic frequency distributions of MTHFR rs1801133 between the HV cases and non-HV controls (p for trend=0.0024). Specifically, individuals with the homozygous TT genotype at MTHFR rs1801133 exhibited a 2.57-fold increased risk of HV (95% confidence interval=1.49-4.42, p=0.0009). However, those with the CT genotype did not show an elevated risk. Stratified analysis showed no correlation between MTHFR rs1801133 genotypic distributions and different age groups (below or above 51 years) or sex (both p>0.05). Furthermore, no associations were identified between MTHFR rs1801133 and height, weight, or body mass index in relation to HV risk.
Conclusion: The TT genotype of MTHFR rs1801133 is associated with an increased risk of HV. Subgrouping HV patients based on their MTHFR genotypes and related comorbidities, such as rheumatoid arthritis, may offer a new approach to diagnosis.
Keywords: Genotype; Taiwan; hallux valgus; methylenetetrahydrofolate reductase (MTHFR); polymorphism.
Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
The Authors declare no conflicts of interest regarding this study.
Similar articles
-
Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan.Anticancer Res. 2025 May;45(5):1861-1870. doi: 10.21873/anticanres.17565. Anticancer Res. 2025. PMID: 40295056
-
Impact of Vitamin D Receptor Genotypes on Taiwan Hallux Valgus.In Vivo. 2024 Jul-Aug;38(4):1601-1608. doi: 10.21873/invivo.13610. In Vivo. 2024. PMID: 38936889 Free PMC article.
-
The association of methylenetetrahydrofolate reductase genotypes with the risk of childhood leukemia in Taiwan.PLoS One. 2015 Mar 20;10(3):e0119776. doi: 10.1371/journal.pone.0119776. eCollection 2015. PLoS One. 2015. PMID: 25793509 Free PMC article.
-
Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.Biosci Rep. 2020 Feb 28;40(2):BSR20194229. doi: 10.1042/BSR20194229. Biosci Rep. 2020. PMID: 32010931 Free PMC article. Review.
-
Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta-analysis.J Gene Med. 2019 Sep;21(9):e3114. doi: 10.1002/jgm.3114. Epub 2019 Aug 6. J Gene Med. 2019. PMID: 31330573 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources